Opsona wins Outstanding Achievement Award at Ireland’s Champions of EU Research event
Opsona Therapeutics was recently recognized for its success in securing research funding receiving an Outstanding Achievement Award at the recent Enterprise Ireland ‘h’ event.
The award, which was presented by President of Ireland, Michael D. Higgins to Mary Reilly VP Pharmaceutical Development & Operations, recognizes the contribution of Opsona to Ireland’s success in the €50 billion EU research fund known as the Seventh EU Framework Programme for Research (FP7). Since the EU programme commenced in 2007 over 1,200 applicants from Ireland have won €384 million in FP7 funding, the equivalent of €1.5 million per week.
Read more on the European Commission website